Chongqing basic medicine supplement catalogue is published, and nearly 30% of the new exclusive varieties of Chinese patent medicine are from local pharmaceutical enterprises

The selection of Chongqing essential drugs has been completed for nearly three months According to the notice on the publication of the national essential drugs catalogue of Chongqing Municipality (2013 Edition), 310 new essential drugs have been added in Chongqing Yesterday (October 31), "daily economic news" reporter inquired about the directory and found that there are nearly 80 new exclusive varieties of Chinese patent medicine in the directory, and about 30% of them are produced by local pharmaceutical enterprises in Chongqing To this end, yesterday, Deng Xingren, who is in charge of the basic drug supplement work of Chongqing Health Bureau, said that all pharmaceutical enterprises in the country are on the same platform for this supplement work, which is carried out in accordance with the relevant requirements of the state For the question of why the products of local enterprises account for a relatively high proportion of the exclusive varieties of Chinese patent medicine, the celebrity said that in this process, he did not clearly indicate that there is a preferential policy for local pharmaceutical enterprises Strategy Some market analysts believe that the supplement of local basic drugs will have a great impact on the current pharmaceutical market pattern, and different levels of "local characteristics" are difficult to form a check and balance on the problems of "supporting medicine with drugs" and higher drug prices Recently, Chongqing Municipal Health Bureau announced that the national essential drug Chongqing supplementary drug catalogue (2013 version) will be officially implemented from now on, which means that the new version of Chongqing basic drug catalogue supplementary work started in August this year has ended The list of complementary base drugs in Chongqing edition includes 159 varieties of chemical drugs and biological products, 151 varieties of Chinese patent medicines, a total of 310 varieties Compared with the 2010 edition of Chongqing basic drug supplement catalogue, the number of chemical and biological products increased by 21, and the number of Chinese patent medicines increased by 76, with a total of 97 new varieties In addition, Chongqing Health Bureau also supplemented the dosage forms and specifications of 45 chemical and biological products and 19 Chinese patent medicines in the national basic drug catalogue According to the notice issued by Chongqing Municipal Health Bureau, the catalogue of supplementary drugs of Chongqing Municipality for national essential drugs (2013 version) shall be implemented as of the date of promulgation The catalogue of supplementary drugs of Chongqing Municipality for national essential drugs (2010 version) (Yuwei [2010] No 198) shall be abolished at the same time The actual number of basic drugs implemented in Chongqing is 830 It is worth noting that there are nearly 80 new exclusive varieties of Chinese patent medicines in the new catalogue of Chongqing, accounting for half of the total new base medicines In addition, the reporter of "daily economic news" noted that among the nearly 80 new exclusive varieties of traditional Chinese medicine, 23 kinds of manufacturers are Chongqing local pharmaceutical enterprises, accounting for nearly 30% In this regard, there are opinions in the industry that the directory has strong "local characteristics" and gives priority to local pharmaceutical enterprises In fact, in addition to the above-mentioned "local characteristics", the catalogue also implies "mystery" In the supplementary catalogue of Chongqing, some non exclusive varieties are listed with restrictions on dosage forms and specifications, while many of the restrictions are more like tailor-made for local pharmaceutical enterprises For example, the conditions for antiviral pills are "pill: 2.5G" and "capsule: 11.25mg" According to the information on the official website of the State Food and drug administration, although there are several enterprises producing the above-mentioned drugs, only Sichuan Hezheng Pharmaceutical Co., Ltd meets the above conditions, which is a subsidiary of Laimei pharmaceutical, a listed pharmaceutical enterprise in Chongqing According to the reporter's rough statistics, there are similar phenomena in more than 10 kinds of drugs, including "Taichang mixture, 10ml specification", "breviscapine dispersible tablets, 0.1g/tablet", "Jiuwei Qiang Huo tablet, 0.5g/tablet", etc., and the drug manufacturers that meet the restrictions are all local pharmaceutical enterprises in Chongqing For example, for breviscapine dispersible tablets, only Chongqing Chenlong Pharmaceutical Co., Ltd of the total 4 manufacturers meets the above restrictions "Our selection work is very open The whole evaluation process does not distinguish between local enterprises and non local enterprises Everyone is on the same platform." Deng, who is in charge of basic medicine supplement work at Chongqing Health Bureau, said yesterday that he had not made clear that he would take care of local pharmaceutical enterprises Market pattern changes / in fact, as early as the beginning of August this year when Chongqing started the work of base drug supplement, the market frequently questioned its care for local enterprises The reporter of "daily economic news" learned that the declaration time of enterprises published on the official website by Chongqing Health Bureau was only 4 working days Although the above-mentioned person surnamed Deng denied the doubt of "priority of local enterprises", it is not uncommon for the local basic drug catalogue to add "preference" for local drug enterprises In addition to the large proportion of traditional Chinese medicine varieties, 15 traditional Chinese medicine injections have been included in the previously published catalogue of basic drugs in Guangdong However, there are no new varieties of traditional Chinese medicine injections in the new national catalogue of basic drugs "It's not surprising that Guangdong is hot and humid all the year round, and Guangyao group and other pharmaceutical companies are making traditional Chinese medicine, which is rich in resources." A senior executive of a large pharmaceutical company in Chongqing said "The number of basic drug supplements is limited, and local enterprises are preferred to promote the development of local pharmaceutical industry; at the same time, most of the experts involved in the review of local supplement catalogue are local, and these experts are familiar with and familiar with local pharmaceutical enterprises, so it is inevitable that they have a high vote rate." Said the executives of the large pharmaceutical companies "Under the premise of taking local drug demand as the leading factor, there are more local enterprises entering the market, which will not have a great impact on the market, but if taking local interests as the leading factor, it will destroy the market competition order." Zhou Juyong, an investor who has studied the capital market of the pharmaceutical industry for many years, said In addition, some analysts are worried that at present, there are a large number of base drug supplements in many provinces, which will also have a certain impact on the non base drug market "The expansion of the base drug catalog will inevitably occupy the market space of non base drugs With the promotion of the base drug system, the resources of the whole pharmaceutical market will quickly move closer to it, and the space of medical insurance payment resources will become larger, and the sales volume of non base drugs will be affected." Said the Chongqing pharmaceutical company executive.